Healthcare & Medical Devices Global On demand · 24-48h

Global Infection Control Market Strategic Research Report

Global Infection Control Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Infection Control Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Sterilization Products & Services, Cleaning & Disinfection Products, Protective Barriers, Other Infection Control Products

By Application: Hospitals and Clinics, Ambulatory Surgery Centers, Medical Device Companies, Pharmaceutical and Biologics Manufacturers, Life-Science and Food-Processing Facilities, Other End-Users

Key Players: 3M, STERIS plc, Getinge AB, Ecolab Inc., Fortive (Advanced Sterilization Products), Sotera Health (Sterigenics, Nordion), Cantel Medical, Belimed AG, MMM Group, MELAG Medizintechnik, Halyard Health, Kimberly-Clark Professional, Reckitt Benckiser, Metrex Research, Pal International, PDI Healthcare, Germitec, ASP Johnson & Johnson, Cardinal Health, Eppendorf AG

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 150 pages

개요

Scope of the Report

Anyone assessing the global Infection Control market will find its scope, segmentation, regional coverage and competitive analysis laid out in this report, together with the risks and sensitivities behind the outlook.

Analysis starts from a global definition of the market, then moves to segment-level outlooks by type and application, and finishes with regional and country-level forecasts.

Market Segmentation

Segmentation of the global Infection Control market covers the dimensions below, with a forecast for every segment:

  • By Products & Services: Sterilization Products & Services, Cleaning & Disinfection Products, Protective Barriers and Other Infection Control Products
  • By Service Delivery Mode: In-house Infection Control and Contract Infection Control
  • By End-User: Hospitals and Clinics, Ambulatory Surgery Centers, Medical Device Companies, Pharmaceutical and Biologics Manufacturers, Life-Science and Food-Processing Facilities and Other End-Users

Regional analysis covers Asia Pacific, North America, Europe, the Middle East and Africa and Latin America, with country-level forecasts.

Market Context

Suppliers in healthcare and medical devices generally face long qualification cycles, strict quality requirements and buyers who weigh safety against total cost of care. In markets like Infection Control, technology differentiation, regulatory or safety approvals and supply-chain resilience commonly shape which suppliers hold share.

Competitive Landscape

20 companies are profiled in the report: 3M, STERIS plc, Getinge AB, Ecolab Inc., Fortive (Advanced Sterilization Products), Sotera Health (Sterigenics, Nordion), Cantel Medical, Belimed AG, MMM Group, MELAG Medizintechnik, Halyard Health, Kimberly-Clark Professional, Reckitt Benckiser, Metrex Research, Pal International, PDI Healthcare, Germitec, ASP Johnson & Johnson, Cardinal Health and Eppendorf AG.

Each profile reviews the company's overview, key products and segments, financial performance, business strategy and SWOT, with strategic implications for 2026 to 2032.

What the Report Covers

Coverage is structured around:

  • How the Infection Control market is defined, how large it is and how it is forecast to grow from 2026 to 2032
  • Segment outlook by type and by application
  • Forecasts for Asia Pacific, North America, Europe, the Middle East and Africa and Latin America, plus 22 individual countries
  • The factors expected to push the Infection Control market forward or hold it back, with an impact assessment of each
  • Profiles of key companies, competitive positioning and the strategic moves shaping rivalry in Infection Control
  • Porter's Five Forces, PESTLE and SWOT analysis
  • Trends in technology and innovation, investment and M&A activity, and the long-term outlook for Infection Control

This is an on-demand title: the report is compiled to the scope above and delivered in PDF within 24 to 48 hours of purchase.

Key Questions Answered

  • How large is the global Infection Control market today, and how is it expected to grow between 2026 and 2032?
  • What is driving demand for Infection Control, and what could slow growth?
  • Which products & services segments of Infection Control - Sterilization Products & Services, Cleaning & Disinfection Products and Protective Barriers - are positioned for the strongest growth?
  • How does the Infection Control market differ by service delivery mode (In-house Infection Control and Contract Infection Control)?
  • How do 3M, STERIS plc and Getinge AB and the other profiled companies compare on positioning and strategy in Infection Control?
  • Which technology and innovation trends are most likely to change the Infection Control market?

Who Can Use This Report

  • Manufacturers, suppliers and component makers benchmarking their Infection Control portfolio and planning product, capacity and sourcing strategy
  • Customers, distributors and channel partners such as Hospitals and Clinics, Ambulatory Surgery Centers and Medical Device Companies evaluating demand and sourcing options
  • Investment professionals, advisers and strategy teams looking for a structured view of opportunity and risk
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Sterilization Products & ServicesCleaning & Disinfection ProductsProtective BarriersOther Infection Control Products
By Application
Hospitals and ClinicsAmbulatory Surgery CentersMedical Device CompaniesPharmaceutical and Biologics ManufacturersLife-Science and Food-Processing FacilitiesOther End-Users

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Segment Outlook by Products & Services
  • 2.1.4 Segment Outlook by Service Delivery Mode
  • 2.1.5 Segment Outlook by End-User
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Products & Services
  • 3.1 Market Segmentation by Products & Services
  • 3.1.1 Market by Products & Services Overview
  • 3.1.2 Sterilization Products & Services
  • 3.1.3 Cleaning & Disinfection Products
  • 3.1.4 Protective Barriers
  • 3.1.5 Other Infection Control Products
04Market Segmentation by Service Delivery Mode
  • 4.1 Market Segmentation by Service Delivery Mode
  • 4.1.1 Market by Service Delivery Mode Overview
  • 4.1.2 In-house Infection Control
  • 4.1.3 Contract Infection Control
05Market Segmentation by End-User
  • 5.1 Market Segmentation by End-User
  • 5.1.1 Market by End-User Overview
  • 5.1.2 Hospitals and Clinics
  • 5.1.3 Ambulatory Surgery Centers
  • 5.1.4 Medical Device Companies
  • 5.1.5 Pharmaceutical and Biologics Manufacturers
  • 5.1.6 Life-Science and Food-Processing Facilities
  • 5.1.7 Other End-Users
06Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
07Country-Level Market Forecast
  • 7.1 Asia Pacific
  • 7.1.1 China
  • 7.1.2 Japan
  • 7.1.3 India
  • 7.1.4 Australia
  • 7.1.5 South Korea
  • 7.1.6 Rest of Asia Pacific
  • 7.2 North America
  • 7.2.1 United States
  • 7.2.2 Canada
  • 7.2.3 Mexico
  • 7.2.4 Rest of North America
  • 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 United Kingdom
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
  • 7.4 Middle East & Africa
  • 7.4.1 GCC
  • 7.4.2 South Africa
  • 7.4.3 Rest of Middle East & Africa
  • 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
08Growth Drivers & Inhibitors
  • 8.1 Growth Drivers & Inhibitors
  • 8.1.1 Section Overview
  • 8.1.2 Growth Drivers
  • 8.1.3 Growth Inhibitors
  • 8.1.4 Driver and Inhibitor Impact Assessment
  • 8.1.5 Analyst Perspective
09Key Company Profiles
  • 9.1 3M
  • 9.1.1 Company Overview
  • 9.1.2 Key Products & Segments
  • 9.1.3 Financial Performance (2023–2025)
  • 9.1.4 Business Strategy
  • 9.1.5 SWOT Analysis
  • 9.1.6 Strategic Implications (2026–2032)
  • 9.2 STERIS plc
  • 9.2.1 Company Overview
  • 9.2.2 Key Products & Segments
  • 9.2.3 Financial Performance (2023–2025)
  • 9.2.4 Business Strategy
  • 9.2.5 SWOT Analysis
  • 9.2.6 Strategic Implications (2026–2032)
  • 9.3 Getinge AB
  • 9.3.1 Company Overview
  • 9.3.2 Key Products & Segments
  • 9.3.3 Financial Performance (2023–2025)
  • 9.3.4 Business Strategy
  • 9.3.5 SWOT Analysis
  • 9.3.6 Strategic Implications (2026–2032)
  • 9.4 Ecolab Inc.
  • 9.4.1 Company Overview
  • 9.4.2 Key Products & Segments
  • 9.4.3 Financial Performance (2023–2025)
  • 9.4.4 Business Strategy
  • 9.4.5 SWOT Analysis
  • 9.4.6 Strategic Implications (2026–2032)
  • 9.5 Fortive (Advanced Sterilization Products)
  • 9.5.1 Company Overview
  • 9.5.2 Key Products & Segments
  • 9.5.3 Financial Performance (2023–2025)
  • 9.5.4 Business Strategy
  • 9.5.5 SWOT Analysis
  • 9.5.6 Strategic Implications (2026–2032)
  • 9.6 Sotera Health (Sterigenics, Nordion)
  • 9.6.1 Company Overview
  • 9.6.2 Key Products & Segments
  • 9.6.3 Financial Performance (2023–2025)
  • 9.6.4 Business Strategy
  • 9.6.5 SWOT Analysis
  • 9.6.6 Strategic Implications (2026–2032)
  • 9.7 Cantel Medical
  • 9.7.1 Company Overview
  • 9.7.2 Key Products & Segments
  • 9.7.3 Financial Performance (2023–2025)
  • 9.7.4 Business Strategy
  • 9.7.5 SWOT Analysis
  • 9.7.6 Strategic Implications (2026–2032)
  • 9.8 Belimed AG
  • 9.8.1 Company Overview
  • 9.8.2 Key Products & Segments
  • 9.8.3 Financial Performance (2023–2025)
  • 9.8.4 Business Strategy
  • 9.8.5 SWOT Analysis
  • 9.8.6 Strategic Implications (2026–2032)
  • 9.9 MMM Group
  • 9.9.1 Company Overview
  • 9.9.2 Key Products & Segments
  • 9.9.3 Financial Performance (2023–2025)
  • 9.9.4 Business Strategy
  • 9.9.5 SWOT Analysis
  • 9.9.6 Strategic Implications (2026–2032)
  • 9.10 MELAG Medizintechnik
  • 9.10.1 Company Overview
  • 9.10.2 Key Products & Segments
  • 9.10.3 Financial Performance (2023–2025)
  • 9.10.4 Business Strategy
  • 9.10.5 SWOT Analysis
  • 9.10.6 Strategic Implications (2026–2032)
  • 9.11 Halyard Health
  • 9.11.1 Company Overview
  • 9.11.2 Key Products & Segments
  • 9.11.3 Financial Performance (2023–2025)
  • 9.11.4 Business Strategy
  • 9.11.5 SWOT Analysis
  • 9.11.6 Strategic Implications (2026–2032)
  • 9.12 Kimberly-Clark Professional
  • 9.12.1 Company Overview
  • 9.12.2 Key Products & Segments
  • 9.12.3 Financial Performance (2023–2025)
  • 9.12.4 Business Strategy
  • 9.12.5 SWOT Analysis
  • 9.12.6 Strategic Implications (2026–2032)
  • 9.13 Reckitt Benckiser
  • 9.13.1 Company Overview
  • 9.13.2 Key Products & Segments
  • 9.13.3 Financial Performance (2023–2025)
  • 9.13.4 Business Strategy
  • 9.13.5 SWOT Analysis
  • 9.13.6 Strategic Implications (2026–2032)
  • 9.14 Metrex Research
  • 9.14.1 Company Overview
  • 9.14.2 Key Products & Segments
  • 9.14.3 Financial Performance (2023–2025)
  • 9.14.4 Business Strategy
  • 9.14.5 SWOT Analysis
  • 9.14.6 Strategic Implications (2026–2032)
  • 9.15 Pal International
  • 9.15.1 Company Overview
  • 9.15.2 Key Products & Segments
  • 9.15.3 Financial Performance (2023–2025)
  • 9.15.4 Business Strategy
  • 9.15.5 SWOT Analysis
  • 9.15.6 Strategic Implications (2026–2032)
  • 9.16 PDI Healthcare
  • 9.16.1 Company Overview
  • 9.16.2 Key Products & Segments
  • 9.16.3 Financial Performance (2023–2025)
  • 9.16.4 Business Strategy
  • 9.16.5 SWOT Analysis
  • 9.16.6 Strategic Implications (2026–2032)
  • 9.17 Germitec
  • 9.17.1 Company Overview
  • 9.17.2 Key Products & Segments
  • 9.17.3 Financial Performance (2023–2025)
  • 9.17.4 Business Strategy
  • 9.17.5 SWOT Analysis
  • 9.17.6 Strategic Implications (2026–2032)
  • 9.18 ASP Johnson & Johnson
  • 9.18.1 Company Overview
  • 9.18.2 Key Products & Segments
  • 9.18.3 Financial Performance (2023–2025)
  • 9.18.4 Business Strategy
  • 9.18.5 SWOT Analysis
  • 9.18.6 Strategic Implications (2026–2032)
  • 9.19 Cardinal Health
  • 9.19.1 Company Overview
  • 9.19.2 Key Products & Segments
  • 9.19.3 Financial Performance (2023–2025)
  • 9.19.4 Business Strategy
  • 9.19.5 SWOT Analysis
  • 9.19.6 Strategic Implications (2026–2032)
  • 9.20 Eppendorf AG
  • 9.20.1 Company Overview
  • 9.20.2 Key Products & Segments
  • 9.20.3 Financial Performance (2023–2025)
  • 9.20.4 Business Strategy
  • 9.20.5 SWOT Analysis
  • 9.20.6 Strategic Implications (2026–2032)
10Competitive Landscape
  • 10.1 Competitive Landscape Overview
  • 10.2 Competitive Intensity Assessment
  • 10.3 Key Player Strategies & Positioning
  • 10.4 Competitive Dynamics & Strategic Outlook
  • 10.4.1 Emerging Competitive Threats
  • 10.4.2 Consolidation vs. Fragmentation Outlook
  • 10.4.3 Competitive Response Matrix
  • 10.4.4 Strategic Recommendations, 2026–2032
11Porter's Five Forces Analysis
  • 11.1 Threat of New Entrants
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Threat of Substitutes
  • 11.5 Competitive Rivalry
12PESTLE Analysis
  • 12.1 Political
  • 12.2 Economic
  • 12.3 Social and Demographic
  • 12.4 Technological
  • 12.5 Legal and Regulatory
  • 12.6 Environmental
  • 12.7 Strategic Implications of the PESTLE Assessment
13SWOT Analysis
14Future Trends & Outlook
  • 14.1 Future Trends & Outlook
  • 14.1.1 Trend Summary and Commercial Maturity Assessment
  • 14.1.2 Technology and Innovation Trends
  • 14.1.3 Long-Term Market Outlook
  • 14.1.4 Investment & M&A Activity Outlook
  • 14.1.5 Overall Outlook Assessment

Frequently asked questions

Which regions and countries are covered for Infection Control?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 22 country-level markets including China, Japan, United States, Canada, Germany, United Kingdom, GCC and South Africa.
How is the Infection Control market segmented?
The market is segmented by Products & Services (Sterilization Products & Services, Cleaning & Disinfection Products, Protective Barriers and Other Infection Control Products), Service Delivery Mode (In-house Infection Control and Contract Infection Control) and End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Medical Device Companies, Pharmaceutical and Biologics Manufacturers, Life-Science and Food-Processing Facilities and Other End-Users), with forecasts for each segment.
Who are the key players in the Infection Control market?
Key players profiled include 3M, STERIS plc, Getinge AB, Ecolab, Fortive (Advanced Sterilization Products), Sotera Health (Sterigenics, Nordion), Cantel Medical, Belimed AG, MMM Group, MELAG Medizintechnik and 10 more, among 20 companies covered in total.
Who should buy the Infection Control market report?
The report is intended for manufacturers and solution providers, distributors and end users, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Infection Control market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.